Methods Used in Economic Evaluations of Chronic Kidney Disease Testing — A Systematic Review

• Andrew J. Sutton,

  Affiliation Health Economics Unit, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Katie Breheny ,

  * E-mail: k.breheny@bham.ac.uk

  Affiliation Health Economics Unit, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Jon Deeks,

  Affiliation School of Health and Population Sciences, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Kamlesh Khunti,

  Affiliation University of Leicester, Leicester, United Kingdom

  ⨯
• Claire Sharpe,

  Affiliation King’s College London, London, United Kingdom

  ⨯
• Ryan S. Ottridge,

  Affiliation Birmingham Clinical Trials Unit, School of Cancer Sciences, Robert Aitken Institute, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Paul E. Stevens,

  Affiliation Kent Kidney Care Centre, East Kent Hospitals University NHS Foundation Trust, Canterbury, Kent, United Kingdom

  ⨯
• Paul Cockwell,

  Affiliation Queen Elizabeth Hospital Birmingham, Division of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Philp A. Kalra,

  Affiliation Department of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, United Kingdom

  ⨯
• Edmund J. Lamb,

  Affiliation Clinical Biochemistry, East Kent Hospitals University NHS Foundation Trust, Canterbury Kent, United Kingdom

  ⨯
• eGFR-C study group

  ¶Membership of the eGFR-C study group is provided in the Acknowledgments.

  ⨯